# Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients

> **NCT01907347** · — · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 1000 (actual)

## Conditions studied

- Intensive Care Unit Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01907347
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-01
- **Primary completion:** 2014-08-15
- **Final completion:** 2014-08-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2017-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01907347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01907347, "Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01907347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*